- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
DeJarnette, Dynamic Healthcare develop integrated RIS/PACS
DeJarnette Research Systems is partnering with Dynamic Healthcare Technologies to develop a platform for an integrated RIS/PACS offering. The collaboration will enhance and extend existing capabilities in Dynamic's RadPlus RIS and
DeJarnette Research Systems is partnering with Dynamic Healthcare Technologies to develop a platform for an integrated RIS/PACS offering. The collaboration will enhance and extend existing capabilities in Dynamic's RadPlus RIS and DeJarnette's PACS by combining Dynamic's expertise in radiology scheduling and workflow processes with DeJarnette's image management knowledge. Each firm will exhibit different applications utilizing these integrated technologies at the RSNA meeting.
In related news, DeJarnette and Voxar have expanded the cross-licensing agreement they signed in 1998. Their original pact allowed Voxar to incorporate DeJarnette DICOM in its 3-D medical imaging software. Under the amended agreement, DeJarnette will include Voxar's Plug'n View 3D in its VisiShare image display systems.
© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 5.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
